Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001628280-23-041001
Filing Date
2023-12-07
Accepted
2023-12-07 10:13:09
Documents
17
Period of Report
2023-12-07

Document Format Files

Seq Description Document Type Size
1 6-K a231207_6kxmorxvotingright.htm 6-K 13107
2 EX-99.1 exhibit_991.htm EX-99.1 5977
3 EX-99.2 exhibit_992.htm EX-99.2 5115
4 EX-99.3 exhibit_993.htm EX-99.3 5178
5 GRAPHIC exhibit_991001.jpg GRAPHIC 116319
6 GRAPHIC exhibit_991002.jpg GRAPHIC 130249
7 GRAPHIC exhibit_991003.jpg GRAPHIC 124651
8 GRAPHIC exhibit_991004.jpg GRAPHIC 103219
9 GRAPHIC exhibit_991005.jpg GRAPHIC 52798
10 GRAPHIC exhibit_992001.jpg GRAPHIC 116192
11 GRAPHIC exhibit_992002.jpg GRAPHIC 125643
12 GRAPHIC exhibit_992003.jpg GRAPHIC 122523
13 GRAPHIC exhibit_992004.jpg GRAPHIC 66161
14 GRAPHIC exhibit_993001.jpg GRAPHIC 116394
15 GRAPHIC exhibit_993002.jpg GRAPHIC 124721
16 GRAPHIC exhibit_993003.jpg GRAPHIC 114995
17 GRAPHIC exhibit_993004.jpg GRAPHIC 88392
  Complete submission text file 0001628280-23-041001.txt   1962813
Mailing Address SEMMELWEISSTR. 7 PLANEGG 2M 82152
Business Address SEMMELWEISSTR. 7 PLANEGG 2M 82152 49 89 89927-0
MorphoSys AG (Filer) CIK: 0001340243 (see all company filings)

EIN.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38455 | Film No.: 231471321
SIC: 2834 Pharmaceutical Preparations